Kidney function estimated from serum creatinine and cystatin C and peripheral arterial disease in NHANES 1999-2002

Research output: Contribution to journalArticlepeer-review

Abstract

AimsSerum cystatin C, a novel marker of kidney function, is reported to be superior to serum creatinine as a risk factor for atherosclerotic disease, but associations may vary across vascular beds.Methods and resultsA cross-sectional study of chronic kidney disease (CKD) and peripheral arterial disease (PAD) in 3089 adult participants aged 40+ from the 1999-2002 National Health and Nutrition Examination Survey (NHANES). Kidney function, assessed by estimated glomerular filtration rate (eGFR), was determined from serum creatinine and cystatin C using established equations. Peripheral arterial disease defined by an ankle brachial index <0.90. Glomerular filtration rate estimated using cystatin C was more strongly associated with PAD compared with eGFR using serum creatinine before and after multivariable adjustment. Further, after adjustment for cystatin C, kidney function based on serum creatinine was no longer significantly associated with PAD. However, cystatin C remained significantly associated with PAD even after adjustment for GFR estimated by serum creatinine. Compared with optimal kidney function (eGFRserum creatinine ≥60, eGFRcystatin C >90), the odds ratio for PAD was 3.11 (95 confidence interval 1.26-7.64) for preclinical CKD (eGFRserum creatinine ≥60, eGFRcystatin C <76.7) and 5.07 (3.01-8.52) for 'confirmed' CKD (eGFRserum creatinine <60, eGFRcystatin C <60).

Original languageEnglish (US)
Pages (from-to)1918-1925
Number of pages8
JournalEuropean heart journal
Volume30
Issue number15
DOIs
StatePublished - Aug 2009

Keywords

  • Chronic kidney disease
  • Cystatin C
  • Epidemiology
  • Glomerular filtration rate
  • NHANES
  • Peripheral arterial disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Kidney function estimated from serum creatinine and cystatin C and peripheral arterial disease in NHANES 1999-2002'. Together they form a unique fingerprint.

Cite this